throbber
Targeted Exon Sequencing by In-Solution
`Hybrid Selection
`Brendan Blumenstiel,1 Kristian Cibulskis,1 Sheila Fisher,1
`Matthew DeFelice,1 Andrew Barry,1 Tim Fennell,1 Justin Abreu,1
`Brian Minie,1 Maura Costello,1 Geneva Young,1 Jared Maquire,1
`Andrew Kernytsky,1 Alexandre Melnikov,1 Peter Rogov,1 Andreas Gnirke,1 and
`Stacey Gabriel1
`1Broad Institute, Cambridge, Massachusetts
`
`ABSTRACT
`This unit describes a protocol for the targeted enrichment of exons from randomly sheared
`genomic DNA libraries using an in-solution hybrid selection approach for sequencing on
`an Illumina Genome Analyzer II. The steps for designing and ordering a hybrid selection
`oligo pool are reviewed, as are critical steps for performing the preparation and hybrid
`selection of an Illumina paired-end library. Critical parameters, performance metrics, and
`analysis work(cid:223)ow are discussed. Curr. Protoc. Hum. Genet. 66:18.4.1-18.4.24. C(cid:2) 2010
`by John Wiley & Sons, Inc.
`Keywords: exon sequencing r hybrid selection r mutation discovery r
`DNA sequencing r targeting
`
`INTRODUCTION
`The ability to identify rare polymorphisms in the human genome is crucial for dis-
`covering genetic associations and causative mutations related to human disease. With
`the completion of the Human Genome Project (Lander et al., 2001; http://www.
`genome.gov/10001772), the framework was set for establishing a deep understanding of
`genomic variation, its structure, and its role in human disease. While genomic sequenc-
`ing is the most powerful tool for identifying a variety of genetic variants, whole-genome
`sequencing of thousands of samples remains prohibitively expensive, thus requiring
`targeted approaches to sequencing genomic regions of interest (Ng et al., 2009).
`Traditionally, targeted sequencing has been performed using single-plex PCR-based
`ampli(cid:222)cation followed by Sanger sequencing (Sj¤oblom et al., 2006). For a multitude of
`reasons including cost and logistic work(cid:223)ow, PCR-based targeting is no longer a cost-
`effective match for many of the new next-generation sequencing technologies emerging
`on the market. In recent years, several methods of exon targeting by hybrid selection have
`been developed by leveraging the massively parallel synthesis of long oligonucleotides
`on programmable arrays (Li et al., 2008; Gnirke et al., 2009). This relatively inexpensive
`method for simultaneous synthesis of tens of thousands of unique oligos has led to highly
`multiplexed methods for exon sequencing.
`By moving to array-based oligonucleotides ranging from 60 to 170 bp in length, pre-
`cise targeting of relatively short exons across many genes is possible. Programmable
`oligonucleotide microarrays can be used to capture and enrich exons by either solid-
`phase or solution-based hybrid selection. In the solution-based method developed and
`implemented at the Broad Institute, PCR-ampli(cid:222)ed DNA probes are then transcribed
`into biotinylated RNA, which is hybridized in-solution with a randomly sheared genomic
`DNA library. Hybridized DNA-RNA duplexes are pulled down using streptavidin-coated
`magnetic beads. Immobilized beads are then washed, removing non-hybridized DNA.
`
`Current Protocols in Human Genetics 18.4.1-18.4.24, July 2010
`Published online July 2010 in Wiley Interscience (www.interscience.wiley.com).
`DOI: 10.1002/0471142905.hg1804s66
`Copyright C(cid:2) 2010 John Wiley & Sons, Inc.
`
`UNIT 18.4
`
`High-
`Throughput
`Sequencing
`18.4.1
`Supplement 66
`
`00001
`
`EX1020
`
`

`

`The remaining captured DNA is subsequently denatured from the immobilized RNA,
`enriched by PCR, and sequenced on Illumina(cid:146)s Genome Analzyer II (GAII) sequencing
`system (Gnirke et al., 2009).
`Outlined in this unit are the steps for performing solution-based hybrid selection of ex-
`ons and preparing enriched libraries for paired-end Illumina sequencing on the Illumina
`GAII. Steps include genomic DNA shearing (Basic Protocol 1); Illumina paired-end
`library construction (end repair, A base addition, paired-end adapter ligation, PCR en-
`richment, and clean-up; Basic Protocol 2); hybrid selection (Basic Protocol 3); and library
`quanti(cid:222)cation for optimized cluster density using qPCR (Basic Protocol 4). In the Support
`Protocol, we describe several recommendations for performing read alignment, calcu-
`lating meaningful hybrid selection metrics, and visualizing and assessing sequence data
`for overall protocol performance. Speci(cid:222)c challenges and points of sensitivity are further
`discussed, along with speci(cid:222)c performance metrics that can be expected by following the
`published protocols.
`STRATEGIC PLANNING
`Choosing Targets and Baits
`The process for choosing targets is fairly straightforward, and several standard capture
`panels are commercially available, such as the Agilent SureSelect Human All Exon Kit.
`In choosing custom targets for hybrid capture, there are two major areas of consideration:
`target uniqueness and target size.
`The genome-wide uniqueness of the capture targets must be considered. If a region is
`not suf(cid:222)ciently unique in the genome, it may not be able to be aligned uniquely with
`short reads. Therefore, although the DNA fragments may be physically captured and
`sequenced, it is not straightforward to analyze the data. A more critical, related problem
`is targeting regions of high copy number in the genome, such as mitochondrial genes
`and ALU repeats. Targeting these regions is detrimental, not only because the results are
`dif(cid:222)cult to interpret, but because the high representation of these regions in the DNA
`causes them to be oversampled. As an example, in one recent capture experiment, 7%
`of reads mapped to targeted mitochondrial genes, even though those genes, represented
`only 0.1% of the target set (unpub. observ.).
`The total size of the targets to be captured has an effect on the ef(cid:222)ciency of the hybrid
`selection, with smaller target sets causing a smaller fraction of reads to align to the target.
`With large target sets, such as whole-exome capture, over 80% of the reads typically align
`to the desired target. However, with smaller sets of a few hundred genes, often only 50%
`to 70% of reads may align to the target. Once a set of targets is chosen, baits are typically
`tiled across the target with a small overlap between baits, as seen in Figure 18.4.1. The
`(cid:222)gure also illustrates the nomenclature commonly used to refer to regions surrounding
`the targets and baits.
`Biotinylated RNA Baits
`Solution-based hybrid selection involves the hybridization of a prepared paired-end
`Illumina library ((cid:147)pond(cid:148)) with a pool of biotinylated RNA ((cid:147)baits(cid:148)). These RNA baits
`are generated from unique oligonucleotides synthesized on an Agilent programmable
`DNA microarray. Up to 55,000 unique oligos can be synthesized simultaneously; they
`are 150-200 bp in length and include 15-bp universal PCR primer sites at the ex-
`treme ends. Following synthesis, the oligos are stripped from the array substrate and
`are universally PCR ampli(cid:222)ed into double-stranded DNA. A second round of PCR in-
`corporates a T7 promoter site into the amplicon, which is used to transcribe the DNA
`into single-stranded, biotinylated RNAs. This process has recently been commercial-
`ized by Agilent Technologies and is currently being marketed as the SureSelect Target
`
`Current Protocols in Human Genetics
`
`Targeted Exon
`Sequencing by
`In-Solution
`Hybrid Selection
`18.4.2
`Supplement 66
`
`00002
`
`

`

`off target
`
`off target
`
`on target
`
`baits (120-mer)
`
`near bait
`(target +/- 250 b)
`
`on bait
`
`near bait
`(target +/- 250 b)
`
`Figure 18.4.1 Targets, baits, and nomenclature. Sequencing reads can fall into several cate-
`gories depending on where they align along a targeted region of the genome. Bases aligning
`to the exact targeted sequence are considered “on target.” Because RNA bait sequences can
`hang off the ends of the actual target, aligned bases can be “off target” but “on bait.” Addi-
`tionally, because randomly sheared fragments vary in size, it is realistic to expect a proportion
`of aligned bases to be “near bait,” which is considered ±250 bp of thebait sequence. Met-
`rics calculating the percentage of bases falling into these categories are helpful in understand-
`ing the performance of a hybrid selection experiment. For the color version of the figure, go to
`http://www.currentprotocols.com/protocol/hg1804.
`Enrichment System. Agilent has developed a streamlined web interface for uploading
`custom probe sequences that can be synthesized and manufactured into a ready-to-use
`biotinylated RNA pool (https://earray.chem.agilent.com/earray).
`
`DNA Quality and Quantity
`DNA quality and quantity must be considered when compiling a cohort for hybrid
`selection sequencing. If available, DNA samples with more than 3 μg of high-quality
`DNA should be used. Although whole-genome DNA extracted from cell lines and blood
`is preferred, whole-genome ampli(cid:222)ed DNA can be used as long as the starting DNA
`is not highly degraded. Before beginning a hybrid selection study, all samples should
`be quanti(cid:222)ed and an aliquot from each sample should be assessed for quality by gel
`electrophoresis or bioanalyzer.
`
`DNA FRAGMENTATION
`Genomic DNA must be fragmented in order to capture and sequence exons. First, because
`the goal is to sequence only exons and as little background genome as possible, DNA must
`be fragmented to a size that allows maximum sequence coverage of targeted exons with
`minimal sequencing of neighboring intronic regions. Because exons average ∼160 bp
`in length, shearing DNA to a mean length of ∼150 bp enables the ef(cid:222)cient capture and
`sequencing of these small target regions. Second, for optimal clonal cluster ampli(cid:222)cation
`on the (cid:223)ow cell, DNA fragments should range from 200 to 500 bp in length. With a tight
`fragment size distribution, uniformly sized clusters are more easily differentiated from
`one another on the GAII, ultimately increasing sequence yields.
`Several methods for randomly shearing DNA are in use today, including nebulization
`using compressed air, sonication, and hydro-shearing. These methods typically produce
`a wide size distribution and often require the use of a preparative gel and size selection to
`obtain the tight size distribution preferred for exon hybrid selection. To eliminate material
`loss and the time-consuming process of gel-based size selection, we routinely use a
`more recently developed DNA shearing technology called Adaptive Focused Acoustics
`(AFA). The Covaris S-series Sample Prep Station is highly adjustable and allows genomic
`
`Current Protocols in Human Genetics
`
`BASIC
`PROTOCOL 1
`
`High-
`Throughput
`Sequencing
`18.4.3
`Supplement 66
`
`00003
`
`

`

`genomic
`DNA
`
`sheared
`DNA
`
`Band
`size (bp)
`
`2,000
`1,500
`1,000
`700
`
`500
`
`300
`
`150
`
`50
`
`Figure 18.4.2 Sheared genomic DNA size distribution. High-quality genomic DNA was sheared
`using the Covaris instrument. Unsheared gDNA (100 ng) and sheared DNA (200 ng) were run in
`parallel on a 2% agarose gel. After shearing, the bulk of the fragments should run between ∼100
`and 400 bp.
`
`DNA to be sheared into a tight band averaging 150 bp with a distribution of ∼100 to
`400 bp (Fig. 18.4.2). The Covaris instrument uses adjustable acoustic energy that is
`focused into a glass vial containing the diluted DNA samples. The focused energy
`creates tiny bubbles that constantly collapse in a process called cavitation, which shears
`the DNA. By adjusting the energy level and the exposure time, genomic DNA can be
`sheared to many size distributions.
`Materials
`DNA sample (e.g., see APPENDIX 3B)
`Nuclease-free water
`70% (v/v) ethanol
`NanoDrop ND-1000 spectrophotometer
`Covaris S-2 Sample Preparation System
`VWR circulating chiller
`Covaris shearing vial (6 × 16−mm AFA (cid:222)ber vial; cat. no. 520045)
`1.5-ml microcentrifuge tube
`Agencourt AMPure XP kit (Beckman Coulter, cat. no. A63881)
`Magnetic separator (DynaMag Spin Magnet, Invitrogen, cat. no. 123-20D)
`Additional reagents and equipment for DNA quantitation (APPENDIX 3D) and agarose
`gel electrophoresis (UNIT 2.7)
`Dilute DNA sample
`1. Prepare a dilution of DNA sample at a concentration of 3 μg in 100 μl nuclease-free
`water (∼30 ng/μl).
`
`Current Protocols in Human Genetics
`
`Targeted Exon
`Sequencing by
`In-Solution
`Hybrid Selection
`18.4.4
`Supplement 66
`
`00004
`
`

`

`2. Con(cid:222)rm DNA concentration by absorption at 260 nm on a Nanodrop ND-1000
`spectrophotometer (APPENDIX 3D), using nuclease-free water to blank the instrument.
`Shear DNA
`3. Fill a Covaris water bath to the (cid:222)ll line, adjust circulating chiller bath to 4◦C, and
`begin degassing. Allow system to chill and degas for 20 min or more.
`4. Pipet 100 μl DNA sample through the split septum cap of a shearing vial, insert vial
`into holder, and place holder into position.
`5. Adjust shearing parameters and run program as follows:
`Duty cycle
`10%
`Intensity
`5%
`Cycler/burst
`200
`Mode
`frequency sweeping
`# Cycles
`3.
`6. Pipet the sheared sample from the vial to a clean 1.5-ml microcentrifuge tube.
`Clean DNA using AMPure XP beads
`7. Allow AMPure beads to equilibrate to room temperature ∼20 min.
`For additional information about using AMPure beads, see manufacturer(cid:146)s instructions.
`8. Gently shake the bottle to resuspend any beads that may have settled and ensure that
`mixture is homogeneous.
`9. Slowly add 1.8× volume (180 μl) of beads to the sheared DNA.
`10. Vortexbead/reactionmixturefor10secoruntilthemixtureishomogeneous.Incubate
`5 min at room temperature.
`11. Place the tube on a magnetic separator and allow the beads to separate out of solution
`for 2 min until the solution appears clear.
`12. With the tube still on the magnet, slowly pipet off and discard the supernatant.
`13. Gently pipet 500 μl of 70% ethanol into the tube, being careful not to disturb beads.
`Let stand 30 sec and then remove and discard the ethanol wash.
`14. Repeat wash, being sure to remove all ethanol after the second wash.
`15. With tube still on the magnet, allow beads to air dry for 2 min.
`Do not allow beads to over dry and appear cracked, as this will greatly reduce DNA
`recovery.
`Elute DNA
`16. Remove tube from magnet and add 32 μl nuclease-free water to elute DNA.
`17. Brie(cid:223)y vortex to ensure all beads come in contact with eluant.
`18. Place tube on magnetic separator and allow beads to separate for 1 min until liquid
`is clear.
`19. Carefully pipet the eluate to a new labeled tube. Store at −20◦C until end repair
`step.
`Check DNA fragment size
`20. Run 2 μl of eluate on a 2% agarose gel to ensure correct fragment distribution.
`The smear should be from ∼100 to 400 bp with a peak around 150 to 200 bp.
`
`Current Protocols in Human Genetics
`
`High-
`Throughput
`Sequencing
`18.4.5
`Supplement 66
`
`00005
`
`

`

`BASIC
`PROTOCOL 2
`
`Targeted Exon
`Sequencing by
`In-Solution
`Hybrid Selection
`18.4.6
`Supplement 66
`
`PAIRED-END LIBRARY PREPARATION
`Library preparation follows a slightly modi(cid:222)ed Illumina paired-end sample preparation
`protocol by which randomly sheared genomic DNA fragments are modi(cid:222)ed so that they
`can be effectively hybridized to a (cid:223)ow cell, cluster ampli(cid:222)ed, and subsequently sequenced
`on the Genome Analyzer II. Brie(cid:223)y, randomly sheared DNA fragments are end-repaired
`to produce blunt ends. Blunt-ended fragments are extended with a single dATP to produce
`a single A-base overhang to which speci(cid:222)c adapters with a single dTTP overhang can be
`ligated. A universal PCR ampli(cid:222)cation is used to enrich for successfully adapter-ligated
`fragments, increase library concentration, and add an additional utility sequence used to
`hybridize fragments to a (cid:223)ow cell for cluster ampli(cid:222)cation and sequencing.
`Materials
`Illumina Paired End Sample Prep Kit (cat. no. PE-102-1001), containing:
`10× T4 DNA ligase buffer w/10 mM ATP
`T4 polynucleotide kinase
`T4 DNA polymerase
`Klenow fragment (3(cid:5)→5(cid:5) exo) and Klenow buffer
`10 mM dNTP mix
`1 mM dATP
`DNA ligase and 2× buffer
`Nuclease-free water
`Sheared, cleaned DNA sample (see Basic Protocol 1)
`Paired-end oligo mix (Illumina)
`2× Phusion high-(cid:222)delity PCR master mix (Finnzymes, cat. no. F-531S)
`PCR primers, 100 μM each:
`PE1.0: AAT GATACGGCGACCACCGAGATCTACACTCTTTCCCTACAC
`GACGCTCTTCCGATCT
`PE2.0: CAAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTCCTGCT
`GAACCGCTCTTCCGATCT
`96-well PCR plate
`Thermocycler
`Additional reagents and equipment for cleaning DNA with AMPure beads (see
`Basic Protocol 1), agarose gel electrophoresis (UNIT 2.7), and DNA quantitation
`(APPENDIX 3D)
`Perform end repair
`1. Prepare end repair master mix on ice as follows (20 μl/reaction):
`5.0 μl 10× T4 DNA ligase buffer with 10 mM ATP
`2.5 μl T4 polynucleotide kinase
`2.5 μl T4 DNA polymerase
`0.5 μl Klenow fragment
`2.0 μl 10 mM dNTP mix
`7.5 μl nuclease-free water.
`2. Add 20 μl end repair mix to 30 μl sheared, cleaned DNA in a 96-well PCR plate for
`a total reaction volume of 50 μl.
`3. Vortex, spin down, seal, and incubate on a thermocycler as follows:
`25◦C
`30 min
`4◦C
`hold.
`
`Current Protocols in Human Genetics
`
`00006
`
`

`

`4. Clean reaction mixture using AMPure XP beads (see Basic Protocol 1, steps 7 to
`19). Use a 1.8× bead concentration and elute with 32 μl nuclease-free water.
`Carry out A-base addition
`5. Prepare A-base addition mix on ice as follows (18 μl/reaction):
`5.0 μl Klenow buffer
`10.0 μl 1 mM dATP
`3.0 μl Klenow fragment (exo).
`6. Add 18 μl A-base addition mix to 32 μl cleaned, end-repaired DNA in a 96-well
`PCR plate for a total reaction volume of 50 μl.
`7. Vortex, spin down, seal, and incubate on a thermocycler as follows:
`37◦C
`30 min
`4◦C
`hold.
`8. Clean reaction mixture using 1.8× volume AMPure XP beads and elute with 24 μl
`nuclease-free water.
`Ligate adapter
`9. Prepare adapter ligation mix on ice as follows (36 μl/reaction):
`30 μl 2× DNA ligase buffer
`3.9 μl paired-end oligo mix
`2.7 μl DNA ligase.
`10. Add 36 μl adapter ligation mix to 24 μl cleaned, A-tailed DNA in a 96-well PCR
`plate for a total reaction volume of 60 μl.
`11. Vortex, spin down, seal, and incubate on a thermocycler as follows:
`25◦C
`30 min
`4◦C
`hold.
`12. Clean reaction mixture using 1.8× volume AMPure XP beads and elute with 40 μl
`nuclease-free water.
`Enrich by PCR
`13. Prepare PCR master mix on ice as follows (15 μl/reaction):
`50 μl 2× Phusion master mix
`1.0 μl Primer PE1.0
`1.0 μl Primer PE2.0
`8.0 μl nuclease-free water.
`14. Add 60 μl PCR master mix to 40 μl cleaned, adapter-ligated DNA in a 96-well PCR
`plate for a total reaction volume of 100 μl.
`15. Vortex, spin down, seal, and incubate on a thermocycler as follows:
`98◦C
`1 cycle:
`30 sec
`98◦C
`6 cycles:
`10 sec
`65◦C
`30 sec
`72◦C
`30 sec
`72◦C.
`5 min
`1 cycle:
`16. Clean reaction mixture using 1.8× volume AMPure XP beads and elute with 35 μl
`nuclease-free water.
`
`Current Protocols in Human Genetics
`
`High-
`Throughput
`Sequencing
`18.4.7
`Supplement 66
`
`00007
`
`

`

`17. Run 3 μl of cleaned PCR product on a 2% agarose gel to con(cid:222)rm ampli(cid:222)cation.
`Ligation of paired-end adapters and ampli(cid:222)cation using PE1.0/PE2.0 primers adds an
`additional 120 bp of Illumina utility sequence, increasing sheared fragment size by 120 bp.
`The smear should now run from ∼250 to 600 bp, with a peak around 350 bp.
`18. Quantify DNA using the NanoDrop ND-1000 (APPENDIX 3D).
`
`HYBRID SELECTION
`In-solution hybrid selection works on the same principle as any typical DNA microarray.
`In this case, speci(cid:222)c capture of targeted exons is accomplished by mixing single-stranded
`biotinylated RNA baits with a denatured Illumina paired-end library under high strin-
`gency conditions. A 24-hour incubation at 65◦C drives the speci(cid:222)c hybridization of
`DNA and RNA based on sequence complementarity. To wash away non-hybridized
`DNA fragments, biotinylated DNA-RNA duplexes are immobilized using streptavidin-
`coated paramagnetic beads and are pulled out of solution using a magnetic separator.
`Repeated washing of beads at high stringency removes non-speci(cid:222)cally hybridized DNA
`fragments. Captured DNA fragments are then chemically denatured from the immo-
`bilized RNA with sodium hydroxide. The released DNA fragments are cleaned and
`PCR-enriched to produce a highly enriched targeted exon library ready for sequencing
`on the Illumina Genome Analyzer.
`Materials
`Adapter-ligated DNA (see Basic Protocol 2)
`50× Denhardt(cid:146)s solution
`20× SSPE
`Nuclease-free water
`10% SDS
`0.5 M EDTA
`1.0 mg/ml human Cot-1 DNA (Invitrogen, cat. no. 15279-101)
`10.0 mg/ml salmon sperm DNA (Invitrogen, cat. no. 15632-011)
`Blocking oligos (200 μM each, custom oligos from IDT)
`Oligo 1.0: AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACAC
`GACGCTCTTCCGATCT
`Oligo 2.0: CAAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTCCT
`GCTGAACCGCTCTTCCGATCT
`100 ng/μl Biotinylated RNA Oligo Library (Agilent Technologies SureSelect)
`20 U/μl Superase-In RNAse Inhibitor (Applied Biosystems, cat. no. AM2694)
`Dynabeads M-280 Streptavidin Beads (Invitrogen, cat. no. 112-05D)
`5 M NaCl
`1 M Tris-Cl
`20× SSC
`0.1 N NaOH
`2× Phusion high-(cid:222)delity PCR master mix (Finnzymes, cat. no. F-531S)
`PCR primers, 100 μM each:
`PE1.0: AAT GATACGGCGACCACCGAGATCTACACTCTTTCCCTACAC
`GACGCTCTTCCGATCT
`PE2.0: CAAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTCCTGCT
`GAACCGCTCTTCCGATCT
`NanoDrop ND-1000 spectrophotometer
`Speedvac evaporator
`65◦C heating block with 1.5-ml tube holder
`96-well PCR plates
`1.5-ml microcentrifuge tubes
`
`Current Protocols in Human Genetics
`
`BASIC
`PROTOCOL 3
`
`Targeted Exon
`Sequencing by
`In-Solution
`Hybrid Selection
`18.4.8
`Supplement 66
`
`00008
`
`

`

`Adhesive plate seal
`96-well thermocycler with heated lid
`50 ml conical tube
`Magnetic separator (DynaMag Spin Magnet, Invitrogen, cat. no. 123-20D)
`Additional reagents and equipment for DNA quantitation (APPENDIX 3D) and
`cleaning DNA with AMPure beads (see Basic Protocol 1)
`Hybridize DNA to RNA
`1. EnsurethatpondDNAisataconcentrationof≥100ng/μlbycheckingonaNanodrop
`ND-1000 spectrophotometer (APPENDIX 3D). If concentration is too low, concentrate
`sample in a Speedvac evaporator.
`2. Prepare hybridization buffer in a 1.5-ml tube as follows:
`500 μl 20× SSPE
`240 μl nuclease-free water
`200 μl 50× Denhardt(cid:146)s solution
`20 μl 10% SDS
`20 μl 0.5 M EDTA.
`3. Vortex hybridization buffer and place in a 65◦C heating block. Occasionally re-vortex
`mixture to ensure SDS precipitate is fully dissolved and buffer appears clear.
`4. In a 96-well plate labeled (cid:147)DNA,(cid:148) combine the following in appropriate wells:
`500 ng enriched pond (5.0 μl at 100 ng/μl)
`2.5 μl 1.0 mg/ml human Cot-1 DNA
`2.5 μl 10.0 mg/ml salmon sperm DNA
`1.5 μl 200 μM blocking oligo 1.0
`1.5 μl 200 μM blocking oligo 2.0.
`5. In a 1.5-ml tube labeled (cid:147)bait(cid:148) combine:
`5.0 μl 100 ng/μl biotinylated oligo library (bait)
`1.0 μl 20 U/μl Superase-In RNAse inhibitor
`1.0 μl nuclease-free water.
`6. Seal the DNA plate with adhesive plate seal, vortex, centrifuge brie(cid:223)y, and place on
`a thermocycler. Close lid and start the hybrid selection program as follows:
`95◦C
`5 min
`65◦C
`hold.
`7. Allow DNA to denature for 5 min and then equilibrate to 65◦C for 5 min.
`8. As soon as the DNA plate has stabilized at 65◦C for 2.5 min, place the tube containing
`RNA bait into a 65◦C heating block and set timer for 2.5 min.
`9. Once RNA has incubated for 2.5 min at 65◦C, pause program, open lid of thermo-
`cycler, and remove adhesive seal.
`It is critical to perform the following addition steps quickly to minimize volume loss to
`evaporation while the plate is open and heated at 65◦C.
`10. With the DNA plate still in the thermocycler, remove hybridization buffer from the
`heating block, brie(cid:223)y spin down, and pipet 13 μl hybridization buffer to each sample.
`11. Quickly remove the RNA bait tube from the 65◦C heating block, spin down, and
`pipet 6 μl to each sample.
`
`Current Protocols in Human Genetics
`
`High-
`Throughput
`Sequencing
`18.4.9
`Supplement 66
`
`00009
`
`

`

`12. Mix 10 times with a pipettor set at 10 μl, reseal plate with new adhesive seal, close
`the thermocycler lid, and continue the program.
`13. Incubate hybridization reaction at 65◦C for 24 hr.
`Prepare M-280 streptavidin beads
`14. In a 50-ml conical tube, prepare bead wash buffer as follows:
`19.7 ml nuclease-free water
`5 ml 5 M NaCl
`250 μl 1 M Tris-Cl
`50 μl 0.5 M EDTA.
`15. In a 1.5-ml microcentrifuge tube, combine 50 μl streptavidin beads with 200 μl bead
`wash buffer per sample (e.g., for 5 samples, combine 250 μl beads with 1 ml buffer).
`Vortex for 30 sec.
`16. Place tube on magnetic separator for 2 min to allow beads to settle out of the mixture.
`17. With the tube still on the magnet, use a pipet to remove and discard the supernatant.
`18. Remove the tube from the magnet and add 165 μl bead wash buffer per reaction
`(e.g., for 5 samples, add 825 μl buffer). Resuspend beads by vortexing 30 sec.
`19. Repeat steps 17 and 18 for a total of three washes.
`20. After the (cid:222)nal wash, resuspend beads in 165 μl bead wash buffer per reaction.
`These wash steps remove the storage buffer and are necessary for effective streptavidin-
`biotin binding.
`Capture hybridized DNA/RNA
`21. When hybridization is complete (step 13), remove DNA plate from the thermocycler
`and transfer each reaction to a labeled 1.5-ml microcentrifuge tube.
`22. Add 165 μl washed beads to each tube. Vortex 10 sec and incubate mixture at room
`temperature for 30 min, vortexing occasionally to keep beads suspended.
`23. Place tubes on magnetic separator and allow to separate for 2 min. Remove and
`discard supernatant. Remove the tube from the magnet.
`24. Prepare low-stringency buffer as follows:
`23.5 ml nuclease-free water
`1.25 ml 20× SSC
`250 μl 10% SDS.
`25. Add 165 μl low-stringency buffer to each sample and incubate at room temperature
`for 15 min.
`26. Place tubes on magnet and allow beads to separate for 2 min. Remove and discard
`supernatant and remove tube from magnet.
`27. Prepare high-stringency buffer as follows:
`24.6 nuclease-free water
`125 μl 20× SSC
`250 μl 10% SDS.
`Aliquot into 1.5-ml tubes and warm to 65◦C in a heating block.
`28. Add 165 μl prewarmed high-stringency buffer to each sample, vortex to resuspend
`beads, and incubate in heating block at 65◦C for 10 min.
`
`Current Protocols in Human Genetics
`
`Targeted Exon
`Sequencing by
`In-Solution
`Hybrid Selection
`18.4.10
`Supplement 66
`
`00010
`
`

`

`29. Place tubes on the magnet and let beads separate for 2 min. Remove and discard the
`supernatant.
`30. Repeat steps 28 and 29 for a total of three washes.
`Denature DNA/RNA hybrid
`31. Denature DNA from bead-bound RNA by adding 50 μl of 0.1 N NaOH to each
`sample. Vortex to resuspend beads and incubate at room temperature for 10 min.
`32. Transfer tube to the magnet and let beads separate for 2 min.
`33. Remove the supernatant (containing the target-selected DNA) and transfer to a fresh
`tube.
`34. Add 50 μl of 1 M Tris-Cl to neutralize the NaOH.
`35. Clean reaction using 1.8× volume AMPure XP beads (see Basic Protocol 1, steps 7
`to 19). Elute (cid:147)catch(cid:148) DNA using 40 μl nuclease-free water.
`Enrich captured DNA
`36. Prepare PCR master mix on ice as follows (15 μl/reaction):
`50 μl 2× Phusion master mix
`1.0 μl Primer PE1.0
`1.0 μl Primer PE2.0
`8.0 μl nuclease-free water.
`37. Add 60 μl PCR master mix to 40 μl cleaned (cid:147)catch(cid:148) DNA in a 96-well PCR plate
`for a total reaction volume of 100 μl.
`38. Vortex, spin down, seal, and incubate on a thermocycler as follows:
`98◦C
`1 cycle:
`30 sec
`98◦C
`12 cycles:
`10 sec
`65◦C
`30 sec
`72◦C
`30 sec
`72◦C.
`5 min
`1 cycle:
`39. Clean reaction mixture using 1.8× volume AMPure XP beads and elute with 35 μl
`nuclease-free water. Store at −20◦C until sequencing.
`40. Quantify DNA using the NanoDrop ND-1000.
`The size of the PCR-ampli(cid:222)ed DNA can be veri(cid:222)ed by agarose gel electrophoresis;
`however, with only twelve cycles of PCR, the product may not be detectable on a gel. The
`subsequent qPCR step will reveal whether there is enough product for sequencing.
`LIBRARY QUANTIFICATION BY qPCR
`Accuratequanti(cid:222)cationofalibraryiscriticalforef(cid:222)cientsequencingontheGenomeAna-
`lyzer. Loading a sample at too high a concentration can saturate the surface chemistry, hin-
`dering the ability of the software to differentiate one cluster from another and ultimately
`reducing the yield of quality reads. Alternatively, loading a sample at too low a concentra-
`tionfailstofullyutilize(cid:223)owcellrealestate,generatinglowsequencingyieldsandlimiting
`the coverage of targets of interest. Because only DNA fragments containing the correct se-
`quences on either end will hybridize and produce clusters on the (cid:223)ow cell, simple quanti(cid:222)-
`cation by OD is often insuf(cid:222)cient for accurately calculating the optimal loading concen-
`tration of a given sample. An effective solution is to run a quantitative real-time PCR assay
`usingapreviouslysequencedpaired-endlibraryasastandardandprimerscomplementary
`to the P5 and P7 sequences used in hybridization and cluster ampli(cid:222)cation on the (cid:223)ow cell.
`
`Current Protocols in Human Genetics
`
`BASIC
`PROTOCOL 4
`
`High-
`Throughput
`Sequencing
`18.4.11
`Supplement 66
`
`00011
`
`

`

`Any well-characterized library can be used for a standard curve, but in many labs the PhiX
`control library provided by Illumina is often well-calibrated for optimal cluster densities.
`Brie(cid:223)y, 1-μl of each library of unknown concentration is diluted 100-fold, and 1μl is
`used as template in a PCR reaction containing SYBR Green stain and P5 and P7 primers.
`Only DNA fragments with both a P5 and P7 sequence on either end will be ampli(cid:222)ed and
`generate (cid:223)uorescent signal by the intercalation of the SYBR stain into double-stranded
`DNA. The qPCR reaction is performed on a real-time PCR machine, which records the
`(cid:223)uorescence intensity for each cycle of ampli(cid:222)cation for each well. Upon completion
`of the cycling program, the software determines an intensity threshold (Rn) within the
`exponential log phase of PCR ampli(cid:222)cation. For each well, the Ct (or cycle-threshold)
`value is calculated by determining the exact cycle at which the (cid:223)uorescence intensity
`crosses the set intensity threshold. The Ct values for the standard curve are plotted, a best-
`(cid:222)t line is calculated, and concentrations for unknown samples are reported (Fig. 18.4.3).
`Materials
`10 nM PhiX Control Library (Illumina, cat. no. 1006471)
`Nuclease-free water
`Target-selected DNA library (see Basic Protocol 3)
`2× Brilliant SYBR Green QPCR Master Mix (Stratagene, cat. no. 600548)
`1 mM ROX Reference Dye
`1.25 μM P5 PCR primer (AATGATACGGCGACCACCGA)
`1.25 μM P7 PCR primer (CAAGCAGAAGACGGCATACGA)
`384 well MicroAmp Optical Reaction Plate (Applied Biosystems, cat. no. 4326270)
`MicroAmp Optical Adhesive Film (Applied Biosystems, cat. no. 4311976)
`ABI 7900HT Real-Time PCR System with SDS V2.3 software (Applied
`Biosystems)
`Create standard curve
`1. Add 2 μl of 10 nM PhiX Control Library to 98 μl nuclease-free water. Vortex well,
`spin down, and label this dilution (cid:147)PhiX Control 20 nM.(cid:148)
`Although the true dilution is now 0.2 nM, the label (20 nM) is scaled up 100-fold as a
`means of accounting for the 1/100 dilution of the library. Entering 100× standard curve
`points in the ABI analysis software allows the read-out to re(cid:223)ect the true concentration
`of the undiluted library.
`2. Add 50 μl of (cid:147)PhiX Control 20 nM(cid:148) to 50 μl nuclease-free water, vortex well, and
`spin down. Continue dilutions to create a seven-step, two-fold serial dilution (20, 10,
`5, 2.5, 1.25, 0.625, and 0.313 nM). Add 50 μl nuclease-free water to another tube
`and label as (cid:147)NTC(cid:148) (No Template Control).
`These labeled concentrations cover a 1/100 dilution of sample template and are at a
`working concentration for the qPCR assay.
`Carry out qPCR quanti(cid:222)cation
`3. Prepare a 1/100 dilution of each library to be quanti(cid:222)ed by carefully pipetting 1 μl
`of library into 99 μl nuclease-free water. Vortex 30 sec and spin down.
`4. Prepare qPCR master mix on ice as follows:
`12.5 μl 2× Brilliant SYBR Green Master Mix
`0.375 μl 2 μM ROX Reference Dye
`1.0 μl 1.25 μM P5 primer
`1.0 μl 1.25 μM P7 primer
`9.125 1.25 μM nuclease-free water.
`The 1 mM reference dye is diluted 1:500 (2 μM) before 0.375 μl is added to the master
`mix.
`
`Current Protocols in Human Genetics
`
`Targeted Exon
`Sequencing by
`In-Solution
`Hybrid Selection
`18.4.12
`Supplement 66
`
`00012
`
`

`

`Figure 18.4.3 qPCR library quantification. Real-time SYBR Green qPCR is used for accurate quantification
`of libraries prior to sequencing. An accurate quantitation is essential for calculating the amount of library to
`be loaded onto a flow cell for optimal cluster density and high sequence yields. Shown in this figure are the
`amplification plots for a two-fold serial dilution standard curve as well as four li

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket